Access
To read this story in full you will need to login or make a payment (see right).
Correspondence
Nature 440, 278 (16 March 2006) | doi:10.1038/440278b; Published online 15 March 2006
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
- More Challenges
- Powered by:
nature jobs
Assistant / Associate / Full Professor
- Northeastern University
- Boston, MA
Technical Manager
- University of Glasgow
- Glasgow, UK
Lyme vaccine demonized by advocacy groups
Edward McSweegan1
- 1692 Barrister Court, Crofton, Maryland 21114, USA
As a microbiologist who managed a federal programme on Lyme disease in the 1990s, I consider that any new clinical trials of a vaccine candidate based on the protein OspA, as mentioned in your News Feature "Uphill struggle" (Nature 439, 524–525; 2006), should be confined to Europe, for three reasons.First, Lyme disease is non-communicable, readily treatable with common antibiotics and geographically localized in the United States.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Engagement of CD47 Inhibits the Contact Hypersensitivity Response Via the Suppression of Motility and B7 Expression by Langerhans CellsJournal of Investigative Dermatology Original Article
